ION356
/ Ionis
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 15, 2024
Orbit Study: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intrathecally Administered ION356 in Participants With Pelizaeus Merzbacher Disease (PMD)
(clinicaltrials.gov)
- P1 | N=24 | Recruiting | Sponsor: Ionis Pharmaceuticals, Inc. | Not yet recruiting ➔ Recruiting
Enrollment open
December 22, 2023
Orbit Study: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intrathecally Administered ION356 in Participants With Pelizaeus Merzbacher Disease (PMD)
(clinicaltrials.gov)
- P1 | N=24 | Not yet recruiting | Sponsor: Ionis Pharmaceuticals, Inc. | Initiation date: Dec 2023 ➔ Mar 2024
Trial initiation date
1 to 2
Of
2
Go to page
1